KUALA LUMPUR, Sept 18 -- More than half the global population is using the Internet in 2019, compared to 24 per cent in 2009, according to global market research company, Euromonitor International.
Smartphones are the go-to device for Internet access with 50 per cent of the global population using a mobile phone to connect this year. In addition, consumers purchased more on mobile phones than any other device for the first time in 2018, spending US$2.7 trillion on products and services, said a statement. (US$1 = RM4.18) “Widespread connectivity ushered in speed, convenience and instant access across life. Now, connected consumers have more power at their fingertips and companies are under pressure to deliver personalised experiences across all channels,” said Euromonitor International head of digital consumer, Michelle Evans. She will uncover the most influential consumer segment of today’s digital world in a live webinar, ‘Five Key Traits Defining Connected Consumers’ on Sept 24 at 9 am CDT. The research company in a survey, also found that industry professionals ranked artificial intelligence and Internet of Things as the top two technologies, impacting businesses over the next five years. More information at https://www.euromonitor.com. -- BERNAMA KUALA LUMPUR, Sept 12 -- Atomwise Inc and Hansoh Pharmaceutical Group Company Limited (Hansoh Pharma) have collaborated to design and discover potential drug candidates.
In a statement, Atomwise, an artificial intelligence (AI) for drug discovery leader said the discovery involved up to 11 undisclosed target proteins in multiple therapeutic areas. Scientific teams from both Atomwise and the China-based Hansoh Pharma will work closely on the programmes. The combination of complementary expertise and technologies has the potential to dramatically increase success and compress timelines for drug discovery and clinical development. Under the terms of the collaboration, Atomwise will receive undisclosed technology access fees, option exercise fees, royalties and income based on sub-licensing or sale of assets created under the collaboration. Meanwhile, Hansoh Pharma will receive rights for development and commercialisation in all fields and geographies. -- BERNAMA KUALA LUMPUR, Sept 6 (Bernama) -- Lithium Werks B.V. has acquired the energy storage system integrator, LiiON®, LLC. The closing of the acquisition is expected to be finalised in the fourth quarter, pending customary closing conditions. Lithium Werks B.V. is a fast-growing lithium-ion battery and portable power solutions group, according to a statement. “As a result of this acquisition, Lithium Werks will be able to offer both new and existing customers a trusted, one-stop platform for fully integrated solutions,” said Lithium Werks chief executive officer (CEO), T. Joseph Fisher III. The LiiON® brand will be retained and its management will join the broader Lithium Werks management team, which extends the Lithium Werks workforce to more than 400 people worldwide. “We are delighted to become part of the Lithium Werks Team, which will help us expand our customer base internationally,” said LiiON® founder and CEO, Gary Gray. The acquisition not only strengthens Lithium Werks’ presence in the United States, but will also help the LiiON® part of the business extend its reach in Europe and Asia. More information at https://lithiumwerks.com. -- BERNAMA |
Archives
October 2023
Categories |